Back to search

Belgium· BE-AMP-SAM051414-00

Locacortene 0.02 %

A flumetasone product containing flumetasone pivalate, registered in Belgium by Amdipharm. The same ATC class is registered in 3 of our 19 countries.

ATC D07AB03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLocacortene 0.02 %ATCD07AB03REGISTER NO.BE-AMP-SAM051414-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Flumetasone is registered in 3 of 19 countries.

Countries holding a registration under ATC D07AB03 (flumetasone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Flumetasone · ATC D07AB03

3 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Flumetasone Pivalate
Manufacturer
Amdipharm
Country
Belgium (BE)
ATC code
D07AB03
ATC class
Flumetasone
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0054742
  • be_apb
    0710772

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Flumetasone in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flumetasone products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Cerson, Cerson Fettcreme
  • Netherlands · Locacorten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/971094f0-1a1d-41f0-8f20-d7ee19a04eca
GET /v1/drugs/971094f0-1a1d-41f0-8f20-d7ee19a04eca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Ointment",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Locacortene 0.02 %",
  "name_fr": "Locacortene 0.02 %",
  "name_nl": "Locacortene 0.02 %",
  "amp_code": "SAM051414-00",
  "strengths": [
    "0.0200",
    "2.5000",
    "0.1800",
    "0.0200"
  ],
  "pack_count": 2,
  "substances": [
    "Flumetasone Pivalate",
    "Cetyl Alcohol",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Flumetasone",
  "authorisation_numbers": [
    "BE051414"
  ]
}

See everything about flumetasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.